Monia BP - Search Results

1

Exposure of human vascular smooth muscle cells to Raf-1 antisense oligodeoxynucleotides: cellular responses and pharmacodynamic implications.

Schumacher C, Cioffi CL, Sharif H, Haston W, Monia BP, Wennogle L. Schumacher C, et al. Among authors: monia bp. Mol Pharmacol. 1998 Jan;53(1):97-104. doi: 10.1124/mol.53.1.97. Mol Pharmacol. 1998. PMID: 9443936

2

Molecular and cellular characterization of baboon C-Raf as a target for antiproliferative effects of antisense oligonucleotides.

Mandiyan S, Schumacher C, Cioffi C, Sharif H, Yuryev A, Lappe R, Monia B, Hanson S, Goff S, Wennogle L. Mandiyan S, et al. Antisense Nucleic Acid Drug Dev. 1997 Dec;7(6):539-48. doi: 10.1089/oli.1.1997.7.539. Antisense Nucleic Acid Drug Dev. 1997. PMID: 9450911

3

Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation.

Cioffi CL, Garay M, Johnston JF, McGraw K, Boggs RT, Hreniuk D, Monia BP. Cioffi CL, et al. Among authors: monia bp. Mol Pharmacol. 1997 Mar;51(3):383-9. Mol Pharmacol. 1997. PMID: 9058592

4

Evaluation of biological role of c-Jun N-terminal kinase using an antisense approach.

Cioffi CL, Monia BP. Cioffi CL, et al. Among authors: monia bp. Methods Enzymol. 2000;314:363-78. doi: 10.1016/s0076-6879(99)14115-6. Methods Enzymol. 2000. PMID: 10565025 No abstract available.

5

Inhibition of hypoxia/reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells.

Garay M, Gaarde W, Monia BP, Nero P, Cioffi CL. Garay M, et al. Among authors: monia bp. Biochem Pharmacol. 2000 May 1;59(9):1033-43. doi: 10.1016/s0006-2952(99)00412-8. Biochem Pharmacol. 2000. PMID: 10704932

6

Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes.

Hreniuk D, Garay M, Gaarde W, Monia BP, McKay RA, Cioffi CL. Hreniuk D, et al. Among authors: monia bp. Mol Pharmacol. 2001 Apr;59(4):867-74. doi: 10.1124/mol.59.4.867. Mol Pharmacol. 2001. PMID: 11259632

7

Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.

Geiger T, Müller M, Monia BP, Fabbro D. Geiger T, et al. Among authors: monia bp. Clin Cancer Res. 1997 Jul;3(7):1179-85. Clin Cancer Res. 1997. PMID: 9815797

8

First- and second-generation antisense oligonucleotide inhibitors targeted against human c-raf kinase.

Monia BP. Monia BP. Ciba Found Symp. 1997;209:107-19; discussion 119-23. doi: 10.1002/9780470515396.ch9. Ciba Found Symp. 1997. PMID: 9383572 Review.

9

Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.

Karras JG, McKay RA, Dean NM, Monia BP. Karras JG, et al. Among authors: monia bp. Mol Pharmacol. 2000 Aug;58(2):380-7. doi: 10.1124/mol.58.2.380. Mol Pharmacol. 2000. PMID: 10908306

10

Inhibition of Cell Growth by Antisense Oligonucleotides Targeting the Growth-Related Protein Kinase c-raf.

Fabbro D, Monia BP, Altmann KH, Geiger T. Fabbro D, et al. Among authors: monia bp. Methods Mol Med. 2000;35:167-88. doi: 10.1385/1-59259-086-1:167. Methods Mol Med. 2000. PMID: 21390806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters